調剤薬局におけるがん患者と薬剤師のコミュニケーションに関するパイロット研究
スポンサーリンク
概要
- 論文の詳細を見る
Pharmacists working in community pharmacies must provide consultation to cancer patients in order to ensure the safety of medical care. However, they only have access to patients' prescription information and cannot check whether patients have given informed consent or not. In this empirical study, we analyzed the current status of communication between cancer patients and community pharmacists. A total of 11 pharmacists in Aichi prefecture agreed to participate. They were interviewed and informed about the oral medication for a simulated cancer patient. The conversations during interviews were analyzed using the Roter Method of Interaction Process Analysis System (RIAS). We also picked out phrases that were deemed unsuitable for communication with patients as an indicator of whether there were any problems in the approach of pharmacists to patients.Our findings were as follows: 1) Even though pharmacists focused on having a good relationship with cancer patients when explaining medications, patient-centered communication was not achieved because patients only listened passively to the explanations; 2) community pharmacists had difficulty in fulfilling their role as a partner in medical care because they were generally unable to gain information on the cancer patient's disease, treatment or psychological state; 3) On average, pharmacists obtained 50.7% of the information on the patient's problems and in some cases, they lacked the communication skills necessary for obtaining information on patient backgrounds or used unsuitable phrases when speaking to them; 4) Pharmacies do not appear to be an appropriate environment for informing patients concerning their medications.It is therefore necessary to develop a training program that will improve pharmacists'skills in communicating with cancer patients.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)